102
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Completeness of TNM cancer staging for melanoma in the Danish Cancer Registry, 2004–2009

, , , , , & show all
Pages 5-10 | Published online: 17 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Henry Jensen, Marie Louise Tørring, Mette Bach Larsen & Peter Vedsted. (2014) Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort. Clinical Epidemiology 6, pages 237-246.
Read now

Articles from other publishers (11)

Line Flytkjær Virgilsen, Henrik Møller & Peter Vedsted. (2019) Travel distance to cancer-diagnostic facilities and tumour stage. Health & Place 60, pages 102208.
Crossref
Marion Piñeros, D Maxwell Parkin, Kevin Ward, Eric Chokunonga, Morten Ervik, Helen Farrugia, Mary Gospodarowicz, Brian O'Sullivan, Isabelle Soerjomataram, Rajaraman Swaminathan, Ariana Znaor, Freddie Bray & James Brierley. (2019) Essential TNM: a registry tool to reduce gaps in cancer staging information. The Lancet Oncology 20:2, pages e103-e111.
Crossref
Sidsel Arnspang Pedersen, Sigrun Alba Johannesdottir Schmidt, Siri Klausen, Anton Pottegård, Søren Friis, Lisbet Rosenkrantz Hölmich & David Gaist. (2018) Melanoma of the Skin in the Danish Cancer Registry and the Danish Melanoma Database. Epidemiology 29:3, pages 442-447.
Crossref
Henry Jensen, Peter Vedsted & Henrik Møller. (2017) Prognosis of cancer in persons with infrequent consultations in general practice: A population-based cohort study. International Journal of Cancer 141:12, pages 2400-2409.
Crossref
Henry Jensen, Marie Louise Tørring & Peter Vedsted. (2017) Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care. BMC Cancer 17:1.
Crossref
Sigurd Broesby-Olsen, Dóra Körmendiné Farkas, Hanne Vestergaard, Anne Pernille Hermann, Michael Boe Møller, Charlotte Gotthard Mortz, Thomas Kielsgaard Kristensen, Carsten Bindslev-Jensen, Henrik Toft Sørensen & Henrik Frederiksen. (2016) Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study. American Journal of Hematology 91:11, pages 1069-1075.
Crossref
Henry Jensen, Marie Louise Tørring, Morten Fenger-Grøn, Frede Olesen, Jens Overgaard & Peter Vedsted. (2016) Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study. British Journal of General Practice 66:647, pages e434-e443.
Crossref
M. Ramos, P. Franch, M. Zaforteza, J. Artero & M. Durán. (2015) Completeness of T, N, M and stage grouping for all cancers in the Mallorca Cancer Registry. BMC Cancer 15:1.
Crossref
Yuelian Sun, Peter Vedsted, Morten Fenger-Grøn, Chun Sen Wu, Bodil Hammer Bech, Jørn Olsen, Michael Eriksen Benros & Mogens Vestergaard. (2015) Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: A Population Based Cohort Study. PLOS ONE 10:9, pages e0138134.
Crossref
Trine Zeeberg Iversen, Mads Hald Andersen & Inge Marie Svane. (2015) The Targeting of Indoleamine 2,3 Dioxygenase -Mediated Immune Escape in Cancer. Basic & Clinical Pharmacology & Toxicology 116:1, pages 19-24.
Crossref
A F Grann, T Frøslev, A B Olesen, H Schmidt & T L Lash. (2013) The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study. British Journal of Cancer 109:1, pages 265-271.
Crossref